Sodium Sulfacetamide And Sulfer Emulsion
FDA Label NDC 73352-750

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Trifluent Pharma for the product Sodium Sulfacetamide And Sulfer Emulsion (NDC 73352-750). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, description, clinical pharmacology, indications, contraindications, warnings, precautions, general, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Warnings

Although rare, sensitivity to sodium sulfacetamide may occur.
Therefore, caution and careful supervision should be observed when prescribing this
drug for patients who may be prone to hypersensitivity to topical sulfonamides.
Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura
hemorrhagica, drug fever, jaundice, and contact dermatitis indicate hypersensitivity
to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved.

FOR EXTERNAL USE ONLY. Keep away from eyes. Keep out of reach of children.
In case of accidental ingestion contact a poison control center immediately. Keep
container tightly closed.

* Please review the disclaimer below.